These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7805702)

  • 1. Macrocyclic molecules and their pharmacological applications.
    Lasagna L
    Eur J Rheumatol Inflamm; 1993; 12(4):3-5. PubMed ID: 7805702
    [No Abstract]   [Full Text] [Related]  

  • 2. Prizes!
    Huskisson EC
    Eur J Rheumatol Inflamm; 1993; 12(4):1-2. PubMed ID: 7805699
    [No Abstract]   [Full Text] [Related]  

  • 3. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
    Lister RE; Acerbi D; Cadel S
    Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
    Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
    Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
    Lee CR; Balfour JA
    Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound.
    Redenti E; Zanol M; Ventura P; Fronza G; Comotti A; Taddei P; Bertoluzza A
    Biospectroscopy; 1999; 5(4):243-51. PubMed ID: 10478955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain.
    Pijak MR; Turcani P; Turcaniova Z; Buran I; Gogolak I; Mihal A; Gazdik F
    Bratisl Lek Listy; 2002; 103(12):467-72. PubMed ID: 12696775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piroxicam-beta-cyclodextrin and photosensitivity reactions.
    Umile A
    Contact Dermatitis; 1999 Jun; 40(6):340-2. PubMed ID: 10385352
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
    Wang D; Miller R; Zheng J; Hu C
    J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
    Reginster JY; Franchimont P
    Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piroxicam-β-cyclodextrin: a GI safer piroxicam.
    Scarpignato C
    Curr Med Chem; 2013; 20(19):2415-37. PubMed ID: 23394552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piroxicam-beta-cyclodextrin and photosensitivity reactions.
    Varela P; Amorim I; Massa A; Sanches M; Silva E
    Contact Dermatitis; 1998 Apr; 38(4):229. PubMed ID: 9565309
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toxicity of NSAIDs].
    Deleuse L
    Rev Med Brux; 1993 Oct; 14(8):262. PubMed ID: 8272684
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic profile of piroxicam beta-cyclodextrin, in rat plasma and lymph.
    Kimura E; Bersani-Amado CA; Sudo LS; Santos SR; Oga S
    Gen Pharmacol; 1997 May; 28(5):695-8. PubMed ID: 9184804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonsteroidal anti-inflammatory agents of the group of oxicam derivatives].
    Suţeanu S; Manuchian M; Oancea P; Macarie O
    Med Interna; 1992; 44(1):16-23. PubMed ID: 1345346
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of efficacy of nizer versus nimesulide tablets in otitis media.
    Dasgupta KS; Deshpande AS; Vedi JN; Patel S
    J Indian Med Assoc; 2002 Oct; 100(10):619. PubMed ID: 12452517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
    Warrington S; Debbas N; Farthing M; Horton M; Umile A
    Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of piroxicam in a new formulation (piroxicam-beta-cyclodextrin) by derivative UV spectrophotometric method and HPLC.
    Basan H; Göğer NG; Ertaş N; Orbey MT
    J Pharm Biomed Anal; 2001 Sep; 26(2):171-8. PubMed ID: 11470194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic diarrhea due to lymphocytic colitis treated with piroxicam beta cyclodextrin].
    Mennecier D; Gros P; Bronstein JA; Thiolet C; Farret O
    Presse Med; 1999 Apr; 28(14):735-7. PubMed ID: 10230409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.